Monograph Details
|
|
Urogenital System
> Miscellaneous urogenital disorders
|
|
K-PHOS M.F. |
| Manufacturer |
|
Beach Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Urinary acidifier. |
| Generic Name |
|
Potassium acid phosphate 155mg, sodium acid phosphate 350mg; equiv. to potassium 1.1mEq and sodium 2.9mEq; scored tabs. |
| Also |
• K-PHOS ORIGINAL
• K-PHOS #2
|
| Indications |
|
Urinary acidification. |
| Children |
|
Not recommended. |
| Adults |
|
2 tabs 4 times a day with a full glass of water. |
| Contraindications |
|
Renal or adrenal insufficiency. Severe hepatic disease. Infected phosphate stones. Hyperphosphatemia. Hyperkalemia (Original). |
| Precautions |
|
Electrolyte restrictions. Cardiac disease. Hypertension. Edema. Monitor serum electrolytes and for GI obstruction. Discontinue if laxation persists after dosage reduction. Hypoparathyroidism. Osteomalacia. Pancreatitis. Dehydration. Toxemia of pregnancy. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Antagonized by antacids. Hyperkalemia with ACE inhibitors, triamterene, spironolactone, amiloride, potassium supplements. Toxicity with digitalis. Hypernatremia with methyldopa, guanethidine, other antihypertensives, corticotropins, mineralocorticoids. |
| Adverse Reactions |
|
Small bowel lesions, laxation, headache, dizziness, hyperacidity, nausea, weakness, confusion, paresthesias, seizures, arrhythmias, shortness of breath, edema. |
| How Supplied |
|
Tabs—100 |
|
|
|
|
